Literature DB >> 18567809

TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.

Angeliki Voulgari1, Stella Voskou, Làszlò Tora, Irwin Davidson, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas.   

Abstract

Activating mutations in the RAS proto-oncogene result in constant stimulation of its downstream pathways, further leading to tumorigenesis. Transcription factor IID (TFIID) can be regulated by cellular signals to specifically alter transcription of particular subsets of genes. To investigate potential links between the regulation of TFIID function and the RAS-induced carcinogenesis, we monitored the expression of the TATA box-binding protein and its associated factors (TAF) in human colon carcinoma cells. We primarily identified TAF12 levels as being up-regulated in cell lines bearing natural RAS mutations or stably overexpressing a mutated RAS isoform via a mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-dependent pathway. We further showed by electrophoretic mobility shift assays and chromatin immunoprecipitation that the ETS1 protein was interacting with an ETS-binding site on the TAF12 promoter and was regulating TAF12 expression. The binding was enhanced in extracts from oncogenic RAS-transformed cells, pointing to a role in the RAS-mediated regulation of TAF12 expression. Reduction of TAF12 levels by small interfering RNA treatment induced a destabilization of the TFIID complex, enhanced E-cadherin mRNA and protein levels, and reduced migration and adhesion properties of RAS-transformed cells with epithelial to mesenchymal transition. Overall, our study indicates the importance of TAF12 in the process of RAS-induced transformation properties of human colon cells and epithelial to mesenchymal transition, most notably those related to increased motility, by regulating specifically expression of genes such as E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567809     DOI: 10.1158/1541-7786.MCR-07-0375

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  6 in total

1.  Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer.

Authors:  Min Zhao; Jingchun Sun; Zhongming Zhao
Journal:  Mol Biosyst       Date:  2013-10-16

2.  Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes.

Authors:  Yiai Tong; Diana Merino; Birgit Nimmervoll; Kirti Gupta; Yong-Dong Wang; David Finkelstein; James Dalton; David W Ellison; Xiaotu Ma; Jinghui Zhang; David Malkin; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

3.  Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

Authors:  Jumpei Teramachi; Yuko Hiruma; Seiichi Ishizuka; Hisako Ishizuka; Jacques P Brown; Laëtitia Michou; Huiling Cao; Deborah L Galson; Mark A Subler; Hua Zhou; David W Dempster; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

4.  Mapping the initiator binding Taf2 subunit in the structure of hydrated yeast TFIID.

Authors:  Gabor Papai; Manish K Tripathi; Christine Ruhlmann; Sebastiaan Werten; Corinne Crucifix; P Anthony Weil; Patrick Schultz
Journal:  Structure       Date:  2009-03-11       Impact factor: 5.006

5.  RegNetB: predicting relevant regulator-gene relationships in localized prostate tumor samples.

Authors:  Angel Alvarez; Peter J Woolf
Journal:  BMC Bioinformatics       Date:  2011-06-17       Impact factor: 3.169

Review 6.  Targeting TBP-Associated Factors in Ovarian Cancer.

Authors:  Jennifer R Ribeiro; Lindsay A Lovasco; Barbara C Vanderhyden; Richard N Freiman
Journal:  Front Oncol       Date:  2014-03-11       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.